Pancreatic Cancer Research

ResearcherUniversity of UlsterActive in the last 2 years

A. P. McHale

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2397-648X; OpenAlex author ID A5070979764. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 11

  1. Paclitaxel and rose bengal loaded microbubbles for the ultrasound targeted chemo-sonodynamic therapy of pancreatic cancer. Co-author DOI 10.1016/j.ejpb.2025.114937↗
  2. Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-022-04418-y↗
  3. Correction to: Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00432-023-04648-8↗
  4. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.06.003↗
  5. Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cance… Last author DOI 10.1016/j.ejpb.2021.03.005↗
  6. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatmen… Co-author DOI 10.1016/j.ejpb.2021.05.018↗
  7. Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2021.07.020↗
  8. An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer. Co-author DOI 10.1016/j.ejpb.2020.10.012↗
  9. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2018.04.018↗
  10. Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2017.07.040↗
  11. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle. Co-author DOI 10.1016/j.biomaterials.2015.11.033↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heather Nesbitt · 10 shared papers, 2016–2026 · strength 1.24
  2. John F. Callan · 9 shared papers, 2016–2023 · strength 0.94
  3. Keiran A. Logan · 7 shared papers, 2018–2026 · strength 0.92
  4. Mark Taylor · 8 shared papers, 2016–2026 · strength 0.92
  5. Nikolitsa Nomikou · 5 shared papers, 2016–2023 · strength 0.53
  6. John F. Callan · 2 shared papers, 2021–2026 · strength 0.40
  7. Jinhui Gao · 3 shared papers, 2020–2021 · strength 0.36
  8. Marym Mohammad-Hadi · 2 shared papers, 2023 · strength 0.31
  9. Brian Ritchie Davidson · 2 shared papers, 2023 · strength 0.31
  10. Jack Wright · 1 shared paper, 2026 · strength 0.27
  11. Paul J Kelly · 3 shared papers, 2017–2021 · strength 0.24
  12. Yingjie Sheng · 2 shared papers, 2017–2018 · strength 0.13
  13. Dean Nicholas · 1 shared paper, 2021 · strength 0.11
  14. Richard J. Browning · 1 shared paper, 2021 · strength 0.11
  15. Katherine A. Vallis · 1 shared paper, 2021 · strength 0.11
  16. Christiana Kartsonaki · 1 shared paper, 2021 · strength 0.11
  17. Conor McEwan · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.